secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sharps Technology Inc. (STSS)
CIK:        0001737995
Form:       8-K
Filed at:   2025-06-04T23:59:59+00:00
Accession:  0001641172-25-013536
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Sharps begins first commercial shipments; transitions to revenue-generating stage
--------------------------------------------------------------------------------

- Initiated shipments under three customer orders; first commercial revenue from $500K total purchase commitments.
- Delivered initial $400K SoloGard order under $50M supply agreement with U.S. IV solutions leader.
- Shipped $100K SecureGard order to Hungarian vaccine provider; first commercial order.
- Began 200K unit shipment of 1mL syringes for Botox delivery pens to Swiss injectable therapies provider.
- CEO Hayes says company now a commercial-stage, revenue-generating firm after R&D and manufacturing investments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737995/000164117225013536/0001641172-25-013536-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737995/000164117225013536/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-013536

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer